The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand

Cancer Research

Volumn 60, Issue 22, 2000, Pages 6259-6265

  Özoren, Nesrin ^a   Kim, Kunhong ^a   Burns, Timothy F ^a   Dicker, David T ^a   Moscioni, A David ^a   El Deiry, Wafik S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CASPASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; COLON CANCER; HUMAN; HUMAN CELL; LIGAND BINDING; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, NON-SMALL-CELL LUNG; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; CASPASE 9; CASPASES; COLONIC NEOPLASMS; CYSTEINE PROTEINASE INHIBITORS; DRUG INTERACTIONS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; FEMALE; HEPATOCYTES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MEMBRANE GLYCOPROTEINS; OLIGOPEPTIDES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033721127     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. The TRAIL to selective tumor death
2. Death receptors: Signaling and modulation
3. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
4. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
5. Molecular determinants of response to TRAIL in killing of normal and cancer cells
6. Killer/dr5, a novel DNA-damage inducible death receptor gene, links the p53-tumor suppressor to caspase activation and apoptotic death
7. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
8. APO2 ligand: A novel lethal weapon against malignant glioma?
9. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
10. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
11. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
12. Steering anti-cancer drugs away from the TRAIL
13. Two CD95 (APO-1/Fas) signaling pathways
14. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells
15. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis
16. TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells
17. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-x(L)-overexpressing chemotherapy-resistant tumor cells
18. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
19. Human liver cell transplantation. Prolonged function in athymic-Gunn and athymic-analbuminemic hybrid rats
20. Hepatocyte transplantation. A potential treatment for liver disease
21. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
22. Detection and analysis of living, growth-inhibited mammalian cells following transfection
23. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB
24. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-κB pathway
25. FADD is required for DR4- and DR5- mediated apoptosis: Lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts
26. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2
27. Mitochondrial release of caspase-2 and -9 during the apoptotic process
28. Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination
29. Reversible physiological alterations in sympathetic neurons deprived of NGF but protected from apoptosis by caspase inhibition or Bax deletion
30. Differential requirement for caspase 9 in apoptotic pathways in vivo
31. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
32. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α
33. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death
34. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis